Intellectual Property India Publishes Patent Application for 'An Inhalable Powder Formulation For Emergency Anti-Asthma Therapy' Filed by Graphic Era Deemed To Be University; and Graphic Era Hill University

MUMBAI, India, Jan. 23 -- Intellectual Property India has published a patent application (202511127260 A) filed by Graphic Era Deemed To Be University; and Graphic Era Hill University, Dehradun, Uttarakhand, on Dec. 16, 2025, for 'an inhalable powder formulation for emergency anti-asthma therapy.'

Inventor(s) include Kumud Pant; and Reenoo Jauhari.

The application for the patent was published on Jan. 23, under issue no. 04/2026.

According to the abstract released by the Intellectual Property India: "The invention provides an inhalable powder formulation for emergency anti-asthma therapy comprising a micronized bronchodilator agent (101), a dispersibility enhancer (102), a stabilizing excipient (103), and engineered particles (104) optimized for deep-lung deposition. The formulation is housed within a dry-powder inhaler (105) incorporating an airflow-activated release mechanism (106) enabling rapid aerosolization even at low inspiratory flow. The system ensures enhanced stability, efficient delivery, and immediate bronchodilation, offering a reliable emergency treatment option for acute asthma episodes."

Disclaimer: Curated by HT Syndication.